Relationship of free thyroxine and triiodothyronine on recurrence in maintenance therapy for bipolar depression

Asian J Psychiatr. 2022 May:71:103086. doi: 10.1016/j.ajp.2022.103086. Epub 2022 Mar 14.

Abstract

Objective: To examine whether thyroid function in the normal range is associated with recurrence of depressive or mania in bipolar disorder patients.

Methods: 104 patients with bipolar disorder in maintenance therapy phase were assigned randomly to mood stabilizer combined with antidepressant group or mood stabilizer group. There were 52 patients in both groups respectively. Clinical symptoms were assessed at baseline, 3rd month, 6th month, 9th month, and 12th month using HAMD-17 and YMRS. Blood samples were analyzed for thyroid function.

Results: There was no statistically significant difference of recurrence rate of depressive episode and mania episode at the end of the 12-months between mood stabilizer combined with antidepressant group and mood stabilizer group. There was significant relation of baseline TT4 (P = 0.020, HR = 0.948), FT3 (P = 0.035, HR = 2.055), and FT4 (P = 0.047, OR=0.769) with the recurrence of depressive episode in mood stabilizer group. The area under curve (AUC) of TT4, FT3, FT4 were 0.685, 0.613, 0.544, respectively. There was significant relation of baseline FT3 (P = 0.044,HR = 4.493) with the recurrence of mania episode for mood stabilizer combined with antidepressants group. The AUC of FT3 was 0.806.

Conclusion: Low level of TT4, FT4 and high level of FT3 within normal-range were related with the recurrence of depressive episode in the maintenance treatment with mood stabilizer of bipolar disorder. High level of FT3 within normal-range were related with recurrence of mania when mood stabilizer combined with antidepressants were used in the maintenance treatment of bipolar disorder.

Keywords: Bipolar disorder; Maintenance treatment; Normal-range thyroid function; Recurrence.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Antipsychotic Agents* / therapeutic use
  • Bipolar Disorder* / diagnosis
  • Bipolar Disorder* / drug therapy
  • Humans
  • Mania
  • Thyroxine / therapeutic use
  • Triiodothyronine

Substances

  • Antidepressive Agents
  • Antipsychotic Agents
  • Triiodothyronine
  • Thyroxine